Lefi A, Asmarani D, Dharmadjati B, Suwanto D, Saputra M, Pravitasari V, Anandita F. Efficacy of the Optimal Dosage of Lisinopril in Inhibiting Myofibroblast Differentiation for Attenuating Rheumatic Heart Disease Progression: An in Vitro Study. Res Heart Yield Transl Med. 2024;19(4):256-263.